Arcadia Biosciences Inc. (RKDA)
NASDAQ: RKDA
· Real-Time Price · USD
4.41
-0.22 (-4.75%)
At close: Aug 14, 2025, 3:40 PM
4.35
-1.36%
Pre-market: Aug 15, 2025, 08:00 AM EDT
Arcadia Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 2.6M | -4.04M | -2.4M | 1.06M | -2.42M | -2.62M | -2.57M | 818K | -9.38M | -4.33M | -2.88M | -3.8M | -4.61M | -9.56M | -2.84M | -5.42M | 1.68M |
Depreciation & Amortization | 13K | 21K | -153K | 17K | 228K | 222K | 89K | 67K | 71K | 86K | 90K | 141K | 162K | 209K | 304K | 276K | 256K |
Stock-Based Compensation | 78K | 117K | 155K | 102K | 138K | 144K | 162K | 199K | 212K | 209K | 314K | 323K | 260K | 506K | 354K | 356K | 325K |
Other Working Capital | n/a | 350K | 1.24M | -253K | 23K | 110K | -320K | -532K | -9K | 901K | -304K | -735K | 235K | 522K | 435K | -996K | -86K |
Other Non-Cash Items | n/a | 1.34M | -89K | -3.5M | 660K | 1.23M | 608K | 6.25M | 5.75M | -530K | -1.96M | 1.49M | -5K | -67K | -119K | 32K | 646K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -1.91M | -796K | -10.33M | n/a | n/a | n/a | n/a | n/a | 2.8M | -3.97M | -1.3M | -7.42M |
Change in Working Capital | n/a | 379K | 736K | -138K | -598K | -1.21M | -381K | -1.8M | -115K | 2.21M | 1.06M | -1.52M | -692K | -547K | -2M | -173K | -200K |
Operating Cash Flow | -1.59M | -2.21M | -1.75M | -2.46M | -3.21M | -4.14M | -2.88M | -4.8M | -3.47M | -2.36M | -3.37M | -3.37M | -4.88M | -6.66M | -8.27M | -6.23M | -4.71M |
Capital Expenditures | n/a | n/a | n/a | -3K | -13K | -52K | n/a | -5K | n/a | -26K | n/a | -6K | -40K | -88K | -206K | -228K | -485K |
Cash Acquisitions | n/a | -8K | n/a | -2M | 17K | 73K | 5K | 284K | 285K | 284K | 285K | 54K | 787K | -4.25M | 2K | -4.25M | 750K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -2.52M | n/a | -5M | n/a | -569K | n/a | n/a | n/a | 25.15M | n/a | n/a | 25.15M |
Sales Maturities Of Investments | n/a | 2.52M | n/a | n/a | n/a | 2.5M | n/a | 5M | n/a | 569K | n/a | n/a | n/a | 1K | n/a | 21.84M | n/a |
Other Investing Acitivies | 500K | -8K | 180K | 8.65M | 17K | 52K | 5K | -5M | 30K | 23K | 56K | 54K | 787K | -20.88M | 2K | -4.25M | -25.15M |
Investing Cash Flow | 500K | 2.52M | 180K | 4.64M | 4K | 52K | 5K | -4.72M | 315K | 281K | 341K | 48K | 747K | -70K | -204K | 17.37M | -485K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -114K | -13K | -10K | -2.01M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -84.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5K | n/a | 4K | n/a | 5K | -84.75M | 7K | n/a | -492K | 936K | -485K | 446K | 4K | n/a | 34K | 6K | -1.14M |
Financial Cash Flow | 5K | n/a | 4K | n/a | 5K | -84.75M | 7K | n/a | 5.5M | 4K | 4.51M | n/a | 4K | -114K | 21K | -4K | 22M |
Net Cash Flow | -1.08M | 306K | -1.57M | 2.19M | -3.2M | -4.09M | -2.87M | -9.51M | 2.35M | -2.08M | 1.49M | -3.32M | -4.13M | -6.84M | -8.45M | 11.13M | 16.8M |
Free Cash Flow | -1.59M | -2.21M | -1.75M | -2.46M | -3.22M | -4.2M | -2.88M | -4.8M | -3.47M | -2.38M | -3.37M | -3.37M | -4.92M | -6.75M | -8.47M | -6.46M | -5.19M |